Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings

What if a biotech company could flip its financial narrative from loss to profit in just a year? Twist Bioscience Corporation (NASDAQ:TWST) has done just that, reporting a surprising third-quarter income that defied analysts’ expectations

On Monday, Twist Bioscience reported a third-quarter income of 33 cents per share, a turnaround from a loss of $1.47 a year ago. The analyst consensus was a loss of 55 cents.

TWST shares are seeing a surge in trading activity. See real-time price here.

The company’s net income of $20.39 million included a gain on the sale of the business of $48.85 million, equivalent to 80 cents. Twist reported an adjusted loss of 47 cents per share, excluding the gain.

The life sciences company reported sales of $96.057 million, up from $81.45 million a year ago, beating the consensus of $95.47 million, and